Project Grant R38AI181012
Award Date
8/8/24
Completion Date
7/31/29
Dollars Obligated
$225K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to train a diverse pool of next-generation physician-scientists to lead the development, implementation, and evaluation of new clinical approaches for diagnosing, treating, and preventing autoimmune, allergic, inflammatory, and infectious diseases across the lifespan. The University of Rochester, the awardee, will...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $245,895 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the Icahn School of Medicine at Mount Sinai. The grant, titled "CRISPR-CAS9 BASE EDITING APPROACHES TO DISCOVER UBIQUITINATION EVENTS PROMOTING FLAVIVIRUS INFECTION", aims to systematically assess the impact of ubiquitination on flavivirus infection using CRISPR-Cas9 base editing techniques. The research will identify novel...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $402,731 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Washington. The grant will support training for four physician-scientists in pediatrics or obstetrics/gynecology residency to complete one year of laboratory-based immunology or infectious disease research. The program aims to increase the number of physician-scientists who can apply microbiology,...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $329,550 Project Grant (Federal Grant Award ID R03AI182613) to the Icahn School of Medicine at Mount Sinai under the Allergy and Infectious Diseases Research (CFDA 93.855) program. The funding is for the development of novel tools, including a floxed CCR5 reporter mouse and specific CCR5 antibodies, to facilitate research on the CCR5 chemokine receptor's function, expression patterns, and involvement in inflammatory...
The federal Project Grant award R25AI175017, titled the "Maryland Infection, Immunization, Intervention, and Impact (M4I) Training Program," was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855: Allergy and Infectious Diseases Research. The $337,719 award will establish a structured training program at the University of Maryland, Baltimore (UMB) to inspire and prepare medical students to pursue careers in infectious disease research. The...
This federal Project Grant award of $195,068 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to define the mechanisms driving increased proliferation, glycolysis, and cell death in early-life CD8 T cells. The research aims to determine the roles of the PI3K/mTOR signaling pathways in T cell function during respiratory syncytial virus (RSV) bronchiolitis and how they relate to disease...
This $1,192,800 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research to characterize four novel host proteins and their role in the alphavirus life cycle, with a focus on the virus exit pathway and early infection steps. The research is being conducted by the Albert Einstein College of Medicine in Bronx, NY, and is expected to provide fundamental...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $379,080 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to Western University of Health Sciences to support a 2.5-month summer research education program. The program will strategically recruit and train 15 qualified, motivated, and research-oriented participants per year from the university's health professional student population, including those from underrepresented and disadvantaged...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $244,440.00 to dissect the mechanisms by which inflammatory Ly6C+ monocytes rapidly mobilize and deliver effector functions to help clear microbial pathogens. The research project, spanning January 2025 to December 2026, will use a combination of genetic experiments, infection models, intravital microscopy, and...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, totaling $134,800. The funding will support research to study the role of HYR1/IFF-like (CAU-HIL) proteins in the virulence of the multi-drug resistant fungal pathogen Candida auris, as well as their potential as vaccine targets using an mRNA...